keyword
https://read.qxmd.com/read/38630963/dynamic-cerebral-autoregulation-is-governed-by-two-time-constants-arterial-transit-time-and-feedback-time-constant
#1
JOURNAL ARTICLE
Stephen J Payne
Dynamic cerebral autoregulation (dCA) is the mechanism that describes how the brain maintains cerebral blood flow approximately constant in response to short-term changes in arterial blood pressure. This is known to be impaired in many different pathological conditions, including ischaemic and haemorrhagic stroke, dementia and traumatic brain injury. Many different approaches have thus been used both to analyse and to quantify this mechanism in a range of healthy and diseased subjects, including data-driven models (in both the time and the frequency domain) and biophysical models...
April 17, 2024: Journal of Physiology
https://read.qxmd.com/read/38630871/update-on-blindness-from-filler-review-of-prognostic-factors-management-approaches-and-a-century-of-published-cases
#2
JOURNAL ARTICLE
Valerie C Doyon, Chaocheng Liu, Rebecca Fitzgerald, Shannon Humphrey, Derek Jones, Jean D A Carruthers, Katie Beleznay
BACKGROUND: Vision loss secondary to aesthetic filler treatment is a rare but disastrous complication. OBJECTIVES: The aim was to update the published cases of blindness after filler injection that have occurred since our group published reviews of 98 cases in 2015 and an additional 48 cases in 2019. METHODS: A literature review was performed to identify all cases of visual complications caused by filler injection published between September 2018 and March 2023...
April 17, 2024: Aesthetic Surgery Journal
https://read.qxmd.com/read/38630693/clinical-practice-of-continuous-rhythm-monitoring-after-embolic-stroke-of-undetermined-source
#3
JOURNAL ARTICLE
Aenne Solvejg von Falkenhausen, Johannes Wischmann, Linus M Keidel, Antonia M Kellnar, Raffael Thaler, Korbinian Lackermair, Heidi L Estner, Günter Höglinger, Steffen Massberg, Stefan Kääb, Lars Kellert, Moritz F Sinner
AIMS: Embolic stroke of undetermined source (ESUS) accounts for up to 20% of ischemic strokes annually. Undetected atrial fibrillation (AF) is one important potential underlying cause. For AF, oral anticoagulation has evolved as the most preferable means of secondary stroke prevention. To detect unrecognized paroxysmal AF, long-term ECG monitoring is required, and implantable cardiac monitors (ICM) appear most suitable. Yet, ICMs are particularly costly, implantation is invasive, and remote monitoring places a personnel burden on health care providers...
2024: PloS One
https://read.qxmd.com/read/38630622/correction-to-xantus-a-real-world-prospective-observational-study-of-patients-treated-with-rivaroxaban-for-stroke-prevention-in-atrial-fibrillation
#4
(no author information available yet)
No abstract text is available yet for this article.
April 17, 2024: European Heart Journal
https://read.qxmd.com/read/38630513/erratum-the-effect-of-mobile-stroke-unit-care-on-functional-outcomes-an-application-of-the-front-door-formula
#5
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
May 1, 2024: Epidemiology
https://read.qxmd.com/read/38630489/extended-clopidogrel-monotherapy-vs-dapt-in-patients-with-acute-coronary-syndromes-at-high-ischemic-and-bleeding-risk-the-opt-birisk-randomized-clinical-trial
#6
JOURNAL ARTICLE
Yi Li, Jing Li, Bin Wang, Quanmin Jing, Yujie Zeng, Aijie Hou, Zhifang Wang, Aijun Liu, Jinliang Zhang, Yaojun Zhang, Ping Zhang, Daming Jiang, Bin Liu, Jiamao Fan, Jun Zhang, Li Li, Guohai Su, Ming Yang, Weihong Jiang, Peng Qu, Hesong Zeng, Lu Li, Miaohan Qiu, Leisheng Ru, Shaoliang Chen, Yujie Zhou, Shubin Qiao, Gregg W Stone, Dominick J Angiolillo, Yaling Han
IMPORTANCE: Purinergic receptor P2Y12 (P2Y12) inhibitor monotherapy after a certain period of dual antiplatelet therapy (DAPT) may be an attractive option of maintenance antiplatelet treatment for patients undergoing percutaneous coronary intervention (PCI) who are at both high bleeding and ischemic risk (birisk). OBJECTIVE: To determine if extended P2Y12 inhibitor monotherapy with clopidogrel is superior to ongoing DAPT with aspirin and clopidogrel after 9 to 12 months of DAPT after PCI in birisk patients with acute coronary syndromes (ACS)...
April 17, 2024: JAMA Cardiology
https://read.qxmd.com/read/38630474/functional-outcomes-associated-with-blood-pressure-decrease-after-endovascular-thrombectomy
#7
JOURNAL ARTICLE
Jae Wook Jung, Kwang Hyun Kim, Jaeseob Yun, Young Dae Kim, JoonNyung Heo, Hyungwoo Lee, Jin Kyo Choi, Il Hyung Lee, In Hwan Lim, Soon-Ho Hong, Byung Moon Kim, Dong Joon Kim, Na Young Shin, Bang-Hoon Cho, Seong Hwan Ahn, Hyungjong Park, Sung-Il Sohn, Jeong-Ho Hong, Tae-Jin Song, Yoonkyung Chang, Gyu Sik Kim, Kwon-Duk Seo, Kijeong Lee, Jun Young Chang, Jung Hwa Seo, Sukyoon Lee, Jang-Hyun Baek, Han-Jin Cho, Dong Hoon Shin, Jinkwon Kim, Joonsang Yoo, Minyoul Baik, Kyung-Yul Lee, Yo Han Jung, Yang-Ha Hwang, Chi Kyung Kim, Jae Guk Kim, Chan Joo Lee, Sungha Park, Soyoung Jeon, Hye Sun Lee, Sun U Kwon, Oh Young Bang, Ji Hoe Heo, Hyo Suk Nam
IMPORTANCE: The associations between blood pressure (BP) decreases induced by medication and functional outcomes in patients with successful endovascular thrombectomy remain uncertain. OBJECTIVE: To evaluate whether BP reductions induced by intravenous BP medications are associated with poor functional outcomes at 3 months. DESIGN, SETTING, AND PARTICIPANTS: This cohort study was a post hoc analysis of the Outcome in Patients Treated With Intra-Arterial Thrombectomy-Optimal Blood Pressure Control trial, a comparison of intensive and conventional BP management during the 24 hours after successful recanalization from June 18, 2020, to November 28, 2022...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38630472/an-aluya5-insertion-in-the-3-utr-of-col4a1-and-cerebral-small-vessel-disease
#8
JOURNAL ARTICLE
Chaker Aloui, Lisa Neumann, Françoise Bergametti, Eric Sartori, Marc Herbreteau, Arnaud Maillard, Thibault Coste, Hélène Morel, Dominique Hervé, Hugues Chabriat, Serge Timsit, Irina Viakhireva, Yves Denoyer, Rémi Allibert, Florence Demurger, Cedric Gollion, Patrick Vermersch, Florence Marchelli, Corinne Blugeon, Sophie Lemoine, Claire Tourtier-Bellosta, Alexis Brouazin, Anne-Louise Leutenegger, Eva Pipiras, Elisabeth Tournier-Lasserve
IMPORTANCE: Cerebral small vessel diseases (CSVDs) account for one-fifth of stroke cases. Numerous familial cases remain unresolved after routine screening of known CSVD genes. OBJECTIVE: To identify novel genes and mechanisms associated with familial CSVD. DESIGN, SETTING, AND PARTICIPANTS: This 2-stage study involved linkage analysis and a case-control study; linkage analysis and whole exome and genome sequencing were used to identify candidate gene variants in 2 large families with CSVD (9 patients with CSVD)...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38630409/glymphatic-impairment-associated-with-neurocognitive-dysfunction-in-moyamoya-disease
#9
JOURNAL ARTICLE
Chaofan Zeng, Yuanren Zhai, Peicong Ge, Chenglong Liu, Xiaofan Yu, Wei Liu, Junsheng Li, Qiheng He, Xingju Liu, Xun Ye, Qian Zhang, Rong Wang, Yan Zhang, Dong Zhang, Jizong Zhao
Glymphatic system alterations have been proved to be associated with cognitive dysfunction in neurodegenerative diseases. The glymphatic pathway has not been elucidated in moyamoya disease (MMD), which was recognized as a chronic hypoperfusion model for neurodegenerative disease. Here, we aimed to investigate the glymphatic system activity and its relation with neurocognition, and associated hallmarks in MMD. We prospectively recruited 30 MMD patients and 30 matched healthy controls (HC). Participants underwent MRI and neurocognition evaluation...
April 17, 2024: Translational Stroke Research
https://read.qxmd.com/read/38630154/clinical-impact-of-the-endo-aortic-clamp-for-redo-mitral-valve-surgery
#10
JOURNAL ARTICLE
Cristina Barbero, Andrea Costamagna, Peter Verbrugghe, Joseph Zacharias, Frank Van Praet, Thierry Bove, Alfonso Agnino, Jörg Kempfert, Mauro Rinaldi
Aim of this study was to compare redo MV surgery patients undergoing right mini-thoracotomy and EAC with redo MV patients undergoing surgery through other approaches. Redo MV patients from 7 European centers were analyzed. Primary endpoint was 30-day mortality; secondary endpoints were stroke, re-exploration, low cardiac output syndrome (LCOS), respiratory failure, and intensive care unit (ICU) and in-hospital length-of-stay. Forty-nine patients underwent right mini-thoracotomy and EAC (22.7%), and 167 (77...
April 17, 2024: Journal of Cardiovascular Translational Research
https://read.qxmd.com/read/38630127/epidemiology-and-risk-factors-for-fat-embolism-in-isolated-lower-extremity-long-bone-fractures
#11
JOURNAL ARTICLE
Natthida Owattanapanich, Meghan Lewis, Subarna Biswas, Elizabeth R Benjamin, Demetrios Demetriades
PURPOSE: Fat embolism syndrome (FES) is a serious complication after orthopedic trauma. The aim of this study was to identify risk factors for FES in isolated lower extremity long bone fractures. METHODS: The National Trauma Data Bank "NTDB" study included patients with isolated femoral and tibial fractures. A total of 344 patients with FES were propensity score matched with 981 patients without FES. Multivariate logistical regression was used to identify independent risk factors for FES...
April 17, 2024: European Journal of Trauma and Emergency Surgery: Official Publication of the European Trauma Society
https://read.qxmd.com/read/38629936/minocycline-to-reduce-inflammation-and-blood-brain-barrier-leakage-in-small-vessel-disease-minerva-a-phase-ii-randomized-double-blind-placebo-controlled-experimental-medicine-trial
#12
JOURNAL ARTICLE
Robin B Brown, Daniel J Tozer, Laurence Loubière, Eric L Harshfield, Young T Hong, Tim D Fryer, Guy B Williams, Martin J Graves, Franklin I Aigbirhio, John T O'Brien, Hugh S Markus
INTRODUCTION: Cerebral small vessel disease (SVD) is a common cause of stroke/vascular dementia with few effective treatments. Neuroinflammation and increased blood-brain barrier (BBB) permeability may influence pathogenesis. In rodent models, minocycline reduced inflammation/BBB permeability. We determined whether minocycline had a similar effect in patients with SVD. METHODS: MINERVA was a single-center, phase II, randomized, double-blind, placebo-controlled trial...
April 17, 2024: Alzheimer's & Dementia: the Journal of the Alzheimer's Association
https://read.qxmd.com/read/38629911/the-improvement-effect-of-acupuncture-combined-with-massage-on-shoulder-pain-after-stroke-and-its-impact-on-limb-function
#13
JOURNAL ARTICLE
Xiaonan Wang, Shaofeng Sun, Dongsheng Yu, Hua Yu
No abstract text is available yet for this article.
April 17, 2024: Minerva Medica
https://read.qxmd.com/read/38629845/developmental-priming-of-early-cerebrovascular-ageing-implications-across-a-lifetime
#14
REVIEW
Helen B Stolp, Egle Solito
INTRODUCTION: Neurological conditions such as Alzheimer's disease and stroke represent a substantial health burden to the world's ageing population. Cerebrovascular dysfunction is a key contributor to these conditions, affecting an individual's risk profile, age of onset, and severity of neurological disease. Recent data shows that early-life events, such as maternal health during pregnancy, birth weight and exposure to environmental toxins can 'prime' the vascular system for later changes...
April 2024: International Journal of Geriatric Psychiatry
https://read.qxmd.com/read/38629797/localizing-apraxia-in-corticobasal-syndrome-a-morphometric-mri-study
#15
JOURNAL ARTICLE
Vasilios C Constantinides, George P Paraskevas, Georgios Velonakis, Leonidas Stefanis, Elisabeth Kapaki
Apraxia localization has relied on voxel-based, lesion-symptom mapping studies in left hemisphere stroke patients. Studies on the neural substrates of different manifestations of apraxia in neurodegenerative disorders are scarce. The primary aim of this study was to look into the neural substrates of different manifestations of apraxia in a cohort of corticobasal syndrome patients (CBS) by use of cortical thickness. Twenty-six CBS patients were included in this cross-sectional study. The Goldenberg apraxia test (GAT) was applied...
April 1, 2024: Cerebral Cortex
https://read.qxmd.com/read/38629694/weathering-the-storms-of-climate-change-preparing-persons-with-disabilities-and-the-physiatrists-who-provide-their-care-for-extreme-hurricanes
#16
JOURNAL ARTICLE
Mollie Andreae, James M Shultz, J Marshall Shepherd, Zelde Espinel, Lauren T Shapiro
Climate-driven disasters have disproportionate and often devastating consequences on individuals with disabilities. Warming ocean and air temperatures are fueling more extreme tropical cyclones, further endangering those living in at-risk regions. Although hurricane preparedness is particularly critical for those with functional impairments and/or special medical needs, studies show such persons are less ready for disasters than the general population. This review calls attention to the time-urgent need to improve hurricane readiness among persons with disabilities...
April 17, 2024: PM & R: the Journal of Injury, Function, and Rehabilitation
https://read.qxmd.com/read/38629679/comparative-safety-of-long-acting-vs-short-acting-erythropoiesis-stimulating-agents-among-patients-undergoing-hemodialysis
#17
JOURNAL ARTICLE
Raj Desai, Ikenna Unigwe, Munaza Riaz, Steven M Smith, Ashutosh M Shukla, Rajesh Mohandas, Nakyung Jeon, Haesuk Park
Both short-acting (epoetin alfa or beta) and long-acting (darbepoetin alfa or PEG-epoetin) erythropoiesis-stimulating agents (ESAs) are commonly prescribed for patients with kidney failure undergoing maintenance hemodialysis. We compared the risks of major adverse cardiovascular events (MACE) and of all-cause mortality associated with receipt of short- vs. long-acting ESAs. This retrospective cohort analysis included Medicare hemodialysis beneficiaries aged ≥ 18 years in the United States Renal Data System from January 2015 to December 2017...
April 17, 2024: Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/38629639/novel-germline-jak2-r715t-mutation-causing-pv-like-erythrocytosis-in-3-generations-amelioration-by-ropeg-interferon
#18
JOURNAL ARTICLE
Jihyun Song, Lucie Lanikova, Soo Jin Kim, Nicolas Papadopoulos, Jessica Meznarich, Stefan N Constantinescu, Brynn Parsegov, Jaroslav F Prchal, Josef T Prchal
Polycythemia vera (PV) is a clonal disorder arising from the acquired somatic mutations of the JAK2 gene, including JAK2V617F or several others in exon 12. A 38-year-old female had a stroke at age 32 and found to have elevated hemoglobin, normal leukocytes, normal platelets, and tested negative for JAK2V617F and exon 12 mutations. Next generation sequencing revealed a novel mutation: JAK2R715T in the pseudokinase domain (JH2) at 47.5%. Its presence in her nail DNA confirmed a germline origin. Her mother and her son similarly had erythrocytosis and a JAK2R715T mutation...
April 17, 2024: American Journal of Hematology
https://read.qxmd.com/read/38629629/therapeutic-exploitation-of-ferroptosis
#19
JOURNAL ARTICLE
Magali Walravens, Ine Koeken, Tom Vanden Berghe
Pathological breakdown of membrane lipids through excessive lipid peroxidation (LPO) was first described in the mid-20th century and is now recognized as a form of regulated cell death, dubbed ferroptosis. Accumulating evidence unveils how metabolic regulation restrains peroxidation of phospholipids within cellular membranes, thereby impeding ferroptosis execution. Unleashing these metabolic breaks is currently therapeutically explored to sensitize cancers to ferroptosis inducing anti-cancer therapies. Reversely, these natural ferroptotic defense mechanisms can fail resulting in pathological conditions or diseases such as ischemia-reperfusion injury, multi-organ dysfunction, stroke, infarction, or neurodegenerative diseases...
April 17, 2024: Biochemical Society Transactions
https://read.qxmd.com/read/38629577/co-transplantation-of-autologous-treg-cells-a-groundbreaking-cell-therapy-for-brain-diseases
#20
JOURNAL ARTICLE
Yue Cheng, Yueman Zhang, Peiying Li
Cell therapy and regenerative medicine have made remarkable progress in treating neurodegenerative disorders. Induced pluripotent stem cells (iPSCs) offer a promising source for cell replacement therapies, but their practical application faces challenges due to poor survival and integration after transplantation. Park et al. propose a novel therapeutic strategy involving the co-transplantation of regulatory T cells (Tregs) and iPSC-derived dopamine neurons. This combined approach enhances the survival of transplanted cells and protects against neuroinflammation-induced damage...
April 17, 2024: Journal of Cerebral Blood Flow and Metabolism
keyword
keyword
6277
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.